RE:RE:RE:RE:RE:RE:RE:“Second mouse gets the cheese “Fair enough - On further inspection CG Oncology has 63.48 million shares outstanding - which in comparison to ONCY's 73.4 million shares outstanding - demonstrates that ONCY's acquisition value is somewhere between US$7.5 - $10 Billion, as has been previously outlined.